Pharma Co. Investor Sues Over Misleading Aurinia Deal
A Kezar Life Sciences investor has filed suit asking an Illinois federal judge to halt the company's planned acquisition by a Canadian biopharmaceutical company's U.S. unit unless Kezar fixes the "incomplete...To view the full article, register now.
Already a subscriber? Click here to view full article